Industry News

Thea Pharma Inc launches preservative-free latanoprost ophthalmic solution in the U.S.

Thea Pharma Inc has launched Iyuzeh (latanoprost ophthalmic solution) 0.005% to the U.S. market, according to a press release. This preservative-free latanoprost, previously launched over a decade ago and used by around 1.5 million patients monthly across 46 countries under the brand Monoprost, is now available in the U.S. Iyuzeh...